Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > PP news !

<< Previous

Bullboard Posts

Next >>

Comment by DeathXray33on Nov 15, 2024 10:49am

89 Views

Post# 36314870

RE:RE:PP news !

Maxcitrac wrote:
blackjack0 wrote: I feel this PP closing at 30 cents plus the 45 cent warrants is extremely positive. Finally a pp at or above market close.

I feel the same.
We have to remember that in the email about financing send to investors on 26 Oct 2024...TLT did mention..
This is a quick offering as we are not looking to do a large raise at this time. We feel that we will be able to do a larger capital raise early 2025 at a higher valuation.

This email indicated that Theralase did need just enough money to get to the BTD approval.

I finally made it!!! @ > 1.602 million. It took 10 years of hard work.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading